BACKGROUND: A U-tube drainage catheter (UTDC) is a novel intervention for necrotizing pancreatitis, with multiple benefits: bidirectional flushing, greater interface with large fluid collections, less risk of dislodgement, and creation of a large-diameter fistula tract for potential fistulojejunostomy. We report the first clinical experience with UTDC for necrotizing pancreatitis. METHODS: From 2011 to 2014, all patients undergoing UTDC for necrotizing pancreatitis at our institution were identified. Clinical variables including patient, disease, and intervention-specific characteristics as well as long-term outcomes populated our dataset. RESULTS: Twenty-two patients underwent UTDC for necrotizing pancreatitis; the median follow-up was 10.2 months. Necrotizing pancreatitis was most commonly owing to gallstones (n = 9; 41%), idiopathic disease (n = 5; 23%), and alcohol abuse (n = 4; 18%). During the course of UTDC and definitive operative therapy (when required), patients had median hospital stays of 31 days, 6 interventional radiology procedures, and 6 CT scans. Operative intervention was not necessary in 9 patients (41%). Among the other 13 patients, 4 patients underwent distal pancreatectomy/splenectomy, 8 had a fistulojejunostomy performed, and 1 underwent both procedures. CONCLUSION: UTDC for necrotizing pancreatitis patients is associated with effective drainage and low morbidity/hospital resource utilization. With skilled interventional radiologists and multidisciplinary coordination, this technique is a valuable means of minimizing morbidity for patients with necrotizing pancreatitis.
BACKGROUND: A U-tube drainage catheter (UTDC) is a novel intervention for necrotizing pancreatitis, with multiple benefits: bidirectional flushing, greater interface with large fluid collections, less risk of dislodgement, and creation of a large-diameter fistula tract for potential fistulojejunostomy. We report the first clinical experience with UTDC for necrotizing pancreatitis. METHODS: From 2011 to 2014, all patients undergoing UTDC for necrotizing pancreatitis at our institution were identified. Clinical variables including patient, disease, and intervention-specific characteristics as well as long-term outcomes populated our dataset. RESULTS: Twenty-two patients underwent UTDC for necrotizing pancreatitis; the median follow-up was 10.2 months. Necrotizing pancreatitis was most commonly owing to gallstones (n = 9; 41%), idiopathic disease (n = 5; 23%), and alcohol abuse (n = 4; 18%). During the course of UTDC and definitive operative therapy (when required), patients had median hospital stays of 31 days, 6 interventional radiology procedures, and 6 CT scans. Operative intervention was not necessary in 9 patients (41%). Among the other 13 patients, 4 patients underwent distal pancreatectomy/splenectomy, 8 had a fistulojejunostomy performed, and 1 underwent both procedures. CONCLUSION:UTDC for necrotizing pancreatitispatients is associated with effective drainage and low morbidity/hospital resource utilization. With skilled interventional radiologists and multidisciplinary coordination, this technique is a valuable means of minimizing morbidity for patients with necrotizing pancreatitis.
Authors: Peter Götzinger; Thomas Sautner; Stephan Kriwanek; Philipp Beckerhinn; Murat Barlan; Christian Armbruster; Peter Wamser; Reinhold Függer Journal: World J Surg Date: 2002-02-06 Impact factor: 3.352
Authors: Michael G T Raraty; Christopher M Halloran; Susanna Dodd; Paula Ghaneh; Saxon Connor; Jonathan Evans; Robert Sutton; John P Neoptolemos Journal: Ann Surg Date: 2010-05 Impact factor: 12.969
Authors: Hjalmar C van Santvoort; Olaf J Bakker; Thomas L Bollen; Marc G Besselink; Usama Ahmed Ali; A Marjolein Schrijver; Marja A Boermeester; Harry van Goor; Cornelis H Dejong; Casper H van Eijck; Bert van Ramshorst; Alexander F Schaapherder; Erwin van der Harst; Sijbrand Hofker; Vincent B Nieuwenhuijs; Menno A Brink; Philip M Kruyt; Eric R Manusama; George P van der Schelling; Tom Karsten; Eric J Hesselink; Cornelis J van Laarhoven; Camiel Rosman; Koop Bosscha; Ralph J de Wit; Alexander P Houdijk; Miguel A Cuesta; Peter J Wahab; Hein G Gooszen Journal: Gastroenterology Date: 2011-07-08 Impact factor: 22.682
Authors: Benoy I Babu; Aali J Sheen; Stephen H Lee; Sarah O'Shea; Jane M Eddleston; Ajith K Siriwardena Journal: Ann Surg Date: 2010-05 Impact factor: 12.969
Authors: Hjalmar C van Santvoort; Marc G Besselink; Olaf J Bakker; H Sijbrand Hofker; Marja A Boermeester; Cornelis H Dejong; Harry van Goor; Alexander F Schaapherder; Casper H van Eijck; Thomas L Bollen; Bert van Ramshorst; Vincent B Nieuwenhuijs; Robin Timmer; Johan S Laméris; Philip M Kruyt; Eric R Manusama; Erwin van der Harst; George P van der Schelling; Tom Karsten; Eric J Hesselink; Cornelis J van Laarhoven; Camiel Rosman; Koop Bosscha; Ralph J de Wit; Alexander P Houdijk; Maarten S van Leeuwen; Erik Buskens; Hein G Gooszen Journal: N Engl J Med Date: 2010-04-22 Impact factor: 91.245
Authors: Rajalakshmi R Nair; Andrew M Lowy; Benjamin McIntyre; Jeffrey J Sussman; Jeffrey B Matthews; Syed A Ahmad Journal: Surgery Date: 2007-10 Impact factor: 3.982
Authors: D W da Costa; D Boerma; H C van Santvoort; K D Horvath; J Werner; C R Carter; T L Bollen; H G Gooszen; M G Besselink; O J Bakker Journal: Br J Surg Date: 2013-11-22 Impact factor: 6.939
Authors: Vikrom K Dhar; Jeffrey M Sutton; Brent T Xia; Nick C Levinsky; Gregory C Wilson; Milton Smith; Kyuran A Choe; Jonathan Moulton; Doan Vu; Ross Ristagno; Jeffrey J Sussman; Michael J Edwards; Daniel E Abbott; Syed A Ahmad Journal: J Gastrointest Surg Date: 2017-04-10 Impact factor: 3.452